RxDoctor Payments Data

James Karadimos

Podiatrist · Westborough, MANPI 1134200801

Payments from drug & device makers

$131in general payments, 2019–2025

Across 8 payments — averaging $16.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$44
  • Paratek Pharmaceuticals, Inc.$31
  • Medtronic$24
  • Zimmer Biomet$17
  • Bioventus LLC$15

What the payments were for

  • Food & beverage$131100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$131 in reported general payments places this provider in the 30th percentile of 179 podiatrist providers in Massachusetts.

See all podiatrist providers in Massachusetts

Medicare billing

Part B allowed, 2024
$213,864
Medicare patients
813
Services billed
3,287

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin46$271
Diclofenac Sodium25$243
Methylprednisolone26$223
Ibuprofen13$131

Paid to pharmacies, not to this prescriber.

Other podiatrist in Westborough

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →